Merrimack Pharmaceuticals
MACK
#8753
Rank
โ‚ฌ0.20 B
Marketcap
13,80ย โ‚ฌ
Share price
0.00%
Change (1 day)
8.12%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2024 (TTM): 12,84ย โ‚ฌ

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 12,64ย โ‚ฌ. In 2016 the company made an earnings per share (EPS) of -11,15ย โ‚ฌ an increase over its 2015 EPS that were of -12,04ย โ‚ฌ.

EPS history for Merrimack Pharmaceuticals from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)12,84ย โ‚ฌ
2016-11,15ย โ‚ฌ-7.35%
2015-12,04ย โ‚ฌ65%
2014-7,30ย โ‚ฌ-39.39%
2013-12,04ย โ‚ฌ-54.01%
2012-26,18ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
1,81ย โ‚ฌ-85.71%๐Ÿ‡ซ๐Ÿ‡ท France
Geron
GERN
-0,07297ย โ‚ฌ-100.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
-1,72ย โ‚ฌ-113.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-0,77ย โ‚ฌ-106.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-26,72ย โ‚ฌ-311.33%๐Ÿ‡บ๐Ÿ‡ธ USA